MY187188A - Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer - Google Patents
Derivatives of di(phenylpropanoid) glycerol for the treatment of cancerInfo
- Publication number
- MY187188A MY187188A MYPI2016000361A MYPI2016000361A MY187188A MY 187188 A MY187188 A MY 187188A MY PI2016000361 A MYPI2016000361 A MY PI2016000361A MY PI2016000361 A MYPI2016000361 A MY PI2016000361A MY 187188 A MY187188 A MY 187188A
- Authority
- MY
- Malaysia
- Prior art keywords
- cancer
- alkylcarbonyloxy
- alkoxy
- phenylpropanoid
- glycerol
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title 3
- 229930015704 phenylpropanoid Natural products 0.000 title 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- -1 R6 is H Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25028709P | 2009-10-09 | 2009-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY187188A true MY187188A (en) | 2021-09-09 |
Family
ID=43352967
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012001601A MY160378A (en) | 2009-10-09 | 2010-10-08 | DERIVATES OF Di (PHENYLPROPANOID) GLYCEROL FROM THE TREATMENT OF CANCER |
| MYPI2016000361A MY187188A (en) | 2009-10-09 | 2010-10-08 | Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012001601A MY160378A (en) | 2009-10-09 | 2010-10-08 | DERIVATES OF Di (PHENYLPROPANOID) GLYCEROL FROM THE TREATMENT OF CANCER |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9061993B2 (enExample) |
| EP (1) | EP2486026B1 (enExample) |
| JP (1) | JP5529280B2 (enExample) |
| CN (1) | CN102264713A (enExample) |
| BR (1) | BR112012008204A2 (enExample) |
| CA (1) | CA2715662C (enExample) |
| CY (1) | CY1123161T1 (enExample) |
| DK (1) | DK2486026T3 (enExample) |
| ES (1) | ES2810906T3 (enExample) |
| HR (1) | HRP20201217T1 (enExample) |
| HU (1) | HUE051549T2 (enExample) |
| LT (1) | LT2486026T (enExample) |
| MX (1) | MX360417B (enExample) |
| MY (2) | MY160378A (enExample) |
| PL (1) | PL2486026T3 (enExample) |
| PT (1) | PT2486026T (enExample) |
| RS (1) | RS60667B1 (enExample) |
| SI (1) | SI2486026T1 (enExample) |
| SM (1) | SMT202000428T1 (enExample) |
| WO (1) | WO2011041907A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8907117B2 (en) * | 2011-09-08 | 2014-12-09 | Henry Lowe | Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues |
| US20160106722A1 (en) | 2014-10-21 | 2016-04-21 | Life Plus, LLC | Human therapeutic agents |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857873A (en) * | 1974-02-11 | 1974-12-31 | Warner Lambert Co | 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols |
| CH648753A5 (de) * | 1981-07-22 | 1985-04-15 | Givaudan & Cie Sa | Lichtschutzmittel. |
| CN1238333C (zh) * | 2003-06-18 | 2006-01-25 | 清华大学 | 药物化合物菠萝酰酯及其制备方法和用途 |
| US7713556B2 (en) * | 2006-12-08 | 2010-05-11 | Henry Lowe | Anti-tumor and anti-inflammatory extracts of plant biomass and their uses |
| AU2008205312B2 (en) * | 2007-01-08 | 2013-11-21 | Annji Pharmaceutical Co., Ltd. | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof |
| TWI383251B (zh) * | 2008-01-16 | 2013-01-21 | Eternal Chemical Co Ltd | 感光型聚醯亞胺 |
| KR101074149B1 (ko) * | 2009-04-15 | 2011-10-17 | 한밭대학교 산학협력단 | 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도 |
| US8907117B2 (en) * | 2011-09-08 | 2014-12-09 | Henry Lowe | Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues |
-
2010
- 2010-10-08 CN CN201080003781XA patent/CN102264713A/zh active Pending
- 2010-10-08 BR BR112012008204A patent/BR112012008204A2/pt not_active Application Discontinuation
- 2010-10-08 MY MYPI2012001601A patent/MY160378A/en unknown
- 2010-10-08 CA CA2715662A patent/CA2715662C/en active Active
- 2010-10-08 MY MYPI2016000361A patent/MY187188A/en unknown
- 2010-10-08 SI SI201032026T patent/SI2486026T1/sl unknown
- 2010-10-08 ES ES10821532T patent/ES2810906T3/es active Active
- 2010-10-08 DK DK10821532.8T patent/DK2486026T3/da active
- 2010-10-08 HU HUE10821532A patent/HUE051549T2/hu unknown
- 2010-10-08 PL PL10821532T patent/PL2486026T3/pl unknown
- 2010-10-08 WO PCT/CA2010/001613 patent/WO2011041907A1/en not_active Ceased
- 2010-10-08 SM SM20200428T patent/SMT202000428T1/it unknown
- 2010-10-08 PT PT108215328T patent/PT2486026T/pt unknown
- 2010-10-08 EP EP10821532.8A patent/EP2486026B1/en active Active
- 2010-10-08 MX MX2012004160A patent/MX360417B/es active IP Right Grant
- 2010-10-08 LT LTEP10821532.8T patent/LT2486026T/lt unknown
- 2010-10-08 RS RS20200931A patent/RS60667B1/sr unknown
- 2010-10-08 US US12/901,113 patent/US9061993B2/en active Active
- 2010-10-08 JP JP2012532432A patent/JP5529280B2/ja not_active Expired - Fee Related
- 2010-10-08 HR HRP20201217TT patent/HRP20201217T1/hr unknown
-
2015
- 2015-05-17 US US14/714,318 patent/US10052301B2/en active Active
-
2020
- 2020-08-05 CY CY20201100724T patent/CY1123161T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX360417B (es) | 2018-10-25 |
| CN102264713A (zh) | 2011-11-30 |
| JP5529280B2 (ja) | 2014-06-25 |
| US20110086912A1 (en) | 2011-04-14 |
| JP2013507327A (ja) | 2013-03-04 |
| RS60667B1 (sr) | 2020-09-30 |
| CA2715662C (en) | 2013-05-07 |
| US20150246014A1 (en) | 2015-09-03 |
| MX2012004160A (es) | 2012-09-07 |
| US10052301B2 (en) | 2018-08-21 |
| BR112012008204A2 (pt) | 2017-07-18 |
| HUE051549T2 (hu) | 2021-10-28 |
| EP2486026A1 (en) | 2012-08-15 |
| PT2486026T (pt) | 2020-08-21 |
| SI2486026T1 (sl) | 2020-10-30 |
| US9061993B2 (en) | 2015-06-23 |
| EP2486026B1 (en) | 2020-06-24 |
| SMT202000428T1 (it) | 2020-09-10 |
| CA2715662A1 (en) | 2010-12-14 |
| MY160378A (en) | 2017-03-15 |
| PL2486026T3 (pl) | 2020-11-02 |
| DK2486026T3 (da) | 2020-08-17 |
| WO2011041907A1 (en) | 2011-04-14 |
| CY1123161T1 (el) | 2021-10-29 |
| ES2810906T3 (es) | 2021-03-09 |
| LT2486026T (lt) | 2020-09-10 |
| HRP20201217T1 (hr) | 2020-12-11 |
| EP2486026A4 (en) | 2015-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2848B1 (en) | Organic compounds | |
| EA201270570A1 (ru) | Комбинированная терапия раковых заболеваний с помощью соединений-ингибиторов hsp90 | |
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
| MA31358B1 (fr) | Méthodes de traitement du cancer à l'aide d'inhibiteurs de pi3k alpha à base de pyridopyrimidinone | |
| TW200806299A (en) | Treatment of pain | |
| NZ619259A (en) | Inhibitors of influenza viruses replication | |
| MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
| EA201300860A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
| MX2008010931A (es) | Quinolonas utiles como inhibidores de sintasa de oxido nitrico inducibles. | |
| MX2009009238A (es) | Nuevos inhibidores de fosfodiesterasa. | |
| MX2013010770A (es) | Tratamiento de tumores solidos. | |
| CY1123161T1 (el) | Παραγωγα δι(φαινυλοπροπανοειδους) γλυκερολης για τη θεραπεια του καρκινου | |
| MX2009012613A (es) | Tiazoles substituidos por heteroarilo y su uso como agentes antivirales. | |
| EA200970936A1 (ru) | СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА | |
| MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
| WO2010121675A3 (en) | Thiazolyl-benzimidazoles | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| MX2011012068A (es) | Nucleosidos 2'-fluoro arabino y su utilizaicon. | |
| TW200639159A (en) | Treatment of pain | |
| EA201270347A1 (ru) | Производные апогоссиполона в качестве противоопухолевых агентов | |
| UA98639C2 (en) | Phosphodiesterase inhibitors | |
| TW200714593A (en) | Agent for treatment of solid tumor | |
| ATE479680T1 (de) | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |